Remedios Otero Candelera-rekin lankidetzan egindako argitalpenak (58)

2024

  1. Valoración de la disnea persistente y progresión a hipertensión pulmonar tromboembólica crónica tras tromboembolismo pulmonar agudo sintomático. Análisis conjunto del estudio OSIRIS y SYSPPE

    Revista española de patología torácica, Vol. 36, Núm. 1, pp. 47-48

2023

  1. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Thrombosis Research, Vol. 228, pp. 1-9

2022

  1. Imaging modalities for confirming pulmonary embolism during pregnancy: results from a multicenter international study

    European Radiology, Vol. 32, Núm. 2, pp. 1238-1246

  2. Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 412-417

  3. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    The European respiratory journal, Vol. 59, Núm. 2

2021

  1. Association between preexisting versus newly identified atrial fibrillation and outcomes of patients with acute pulmonary embolism

    Journal of the American Heart Association, Vol. 10, Núm. 17

  2. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

2020

  1. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

    Journal of Thrombosis and Thrombolysis, Vol. 50, Núm. 2, pp. 267-277

  2. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

    Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 8, Núm. 3, pp. 353-359.e1

  3. Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulation

    Thrombosis and Haemostasis, Vol. 120, Núm. 7, pp. 1035-1044

2019

  1. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

    Clinical Cardiology, Vol. 42, Núm. 3, pp. 346-351

2018

  1. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism

    Thrombosis Research, Vol. 164, pp. 40-44

  2. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

    Thrombosis Research, Vol. 164, pp. 69-74

  3. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 4, pp. 684-691

  4. Sex Differences in Patients With Occult Cancer After Venous Thromboembolism

    Clinical and Applied Thrombosis/Hemostasis, Vol. 24, Núm. 3, pp. 489-495

  5. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism

    PLoS ONE, Vol. 13, Núm. 3

2017

  1. Calidad de vida en pacientes diagnosticados de embolia de pulmón aguda sintomática

    Revista Clinica Espanola

  2. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

  3. Response

    Chest

  4. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

    American Journal of Medicine, Vol. 130, Núm. 3, pp. 337-347